Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biotin + zinc + vitamin D is an oral combination nutraceutical product developed and marketed by Bi-nex for the treatment of hair loss and the promotion of hair follicle health. The formulation specifically addresses nutritional deficiencies that can lead to telogen effluvium or thinning hair. Biotin (Vitamin B7) serves as a vital cofactor for enzymes involved in keratin synthesis, the primary structural protein in hair. Zinc is an essential mineral that supports protein synthesis, cellular division, and the structural integrity of the hair shaft, while also modulating hair follicle regression and recovery. Vitamin D interacts with the Vitamin D receptor (VDR) in the hair follicle to regulate the hair growth cycle. This combination is approved in South Korea as a supportive treatment for hair loss related to micronutrient insufficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on biotin + zinc + vitamin D.